Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 31, 2022

SELL
$19.66 - $28.11 $1,966 - $2,811
-100 Closed
0 $0
Q3 2020

Sep 15, 2021

BUY
$21.55 - $33.92 $2,155 - $3,392
100 New
100 $3,000
Q3 2020

Oct 19, 2020

SELL
$21.55 - $33.92 $2,155 - $3,392
-100 Closed
0 $0
Q2 2020

Sep 15, 2021

BUY
$30.8 - $32.99 $3,080 - $3,299
100 New
100 $3,000
Q2 2020

Jul 22, 2020

SELL
$30.8 - $32.99 $3,080 - $3,299
-100 Closed
0 $0
Q1 2020

Sep 15, 2021

BUY
N/A
100 New
100 $3,000
Q1 2020

Apr 28, 2020

SELL
N/A
-100 Closed
0 $0
Q4 2019

Sep 14, 2021

BUY
N/A
100 New
100 $3,000
Q4 2019

Jan 27, 2020

SELL
N/A
-100 Closed
0 $0
Q3 2019

Sep 14, 2021

BUY
N/A
100 New
100 $3,000
Q3 2019

Oct 22, 2019

SELL
N/A
-100 Closed
0 $0
Q2 2019

Sep 14, 2021

BUY
N/A
100 New
100 $3,000
Q2 2019

Jul 31, 2019

SELL
N/A
-100 Closed
0 $0
Q1 2019

Sep 02, 2021

BUY
N/A
100 New
100 $0

Others Institutions Holding RPTX

About Repare Therapeutics Inc.


  • Ticker RPTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,937,800
  • Market Cap $132M
  • Description
  • Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...
More about RPTX
Track This Portfolio

Track Cwm, LLC Portfolio

Follow Cwm, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.